Tobacco, Nicotiana tabacum L., supports cowpea mosaic virus (CPMV) replication and cell-to-cell movement, and thus may serve as a model system to study coat protein-mediated protection against CPMV. A chimeric gene consisting of the cauliflower mosaic virus 35S promoter, CPMV 60K coat proteinsprecursor (CP-P) coding region, and the nopaline synthase polyadenylation signal was transferred to tobacco cv. Burley 21 via the Agrobacterium tumefaciens binary vector system. Gene integration and expression in the transgenic tobacco plants were confirmed by Southern and RNA dot blot analyses. Accumulation of CPMV 60K CP-P in transgenic plants, up to 2 txg/g of wet weight tissue, was detected by ELISA and Western blots. The results of Western blots and immunosorbent electron microscopy further indicated that CPMV CP-P neither undergoes autoproteolysis to generate the mature viral coat proteins nor assembles into virus-like capsids, suggesting that processing of the CP-P may be required for virus assembly. Because CPMV neither induces symptoms in tobacco nor moves systemically, evaluation of the reactions of the transgenic plants to virus inoculation was based on virus accumulation in the inoculated leaves. Results from such infectivity experiments did not differentiate between CP-P expressers and vectortransformed plants. The transgenic tobacco plants expressing CP-P should provide valuable material for investigating comovirus polyprotein processing and capsid assembly in vivo.
Introduction
Transgenic plants expressing viral genes provide useful systems to investigate host-virus gene product interactions, and in some cases demonstrate a potential for disease control. The expression of tobacco mosaic virus (TMV) coat protein in transgenic tobacco plants has been correlated with a delay in symptom development and virus accumulation after inoculation with TMV (Powell Abel et al., 1986; Nelson et al., 1987) . This approach, termed coat protein-mediated protection (Beachy et al., 1990) , has been extended to include a number of viruses such as alfalfa mosaic virus (LoeschFries et al., 1987; Tumer et al., 1987; van Dun et al., 1987 van Dun et al., , 1988a , tobacco streak virus (van Dun et al., 1988a) , tobacco rattle virus (van Dun et aL, 1987 (van Dun et aL, , 1988b , cucumber mosaic virus (Cuozzo et al., 1988) , potato virus X (Hemenway et al., 1988; Hoekema et al., 1989) and potato virus Y (Lawson et al., 1990) .
Coat protein-mediated protection has so far been shown to be applicable to viruses whose capsids contain "~ Present address: Monsanto Agricultural Company, New Products Division, 700 Chesterfield Village Parkway, Chesterfield, Missouri 63198, U.S.A. a single type of coat protein. This strategy has not been pursued with viruses in the comovirus group whose capsids are made up of two types of coat protein. Cowpea mosaic virus (CPMV), the type member of the comovirus group, has a bipartite genome consisting of two separately encapsidated single-stranded positive sense RNAs, designated M (middle component)-RNA and B (bottom component)-RNA. CPMV expresses its genome via the production of large polyproteins which are proteolytically cleaved into mature viral proteins. M-RNA is translated into two large polyproteins of 95K and 105K with overlapping amino acid sequences. These polyproteins are proteolytically cleaved at similar sites to yield two polypeptides of 58K and 48K, derived from the amino-terminal portions of the polyproteins, together with a 60K polyprotein which represents the precursor to both capsid proteins VP37 and VP23 (Goldbach & van Kammen, 1985) . Therefore, it is of interest to determine whether constitutive expression of the coat proteinsprecursor (CP-P) of a comovirus in transgenic plants confers protection against virus infection.
To address this question in a plant system that is readily amenable to transformation and regeneration, we chose to transform tobacco with the CPMV 60K CP-P 0001-0469 © 1992 SGM coding region. Although tobacco is not a systemic host for CPMV, it supports virus replication and limited spread in the inoculated leaf (Huber et al., 1977) . Thus, tobacco may serve as a model system to study CP-Pmediated protection against CPMV. In this paper, we report the production of transgenic tobacco plants that express CPMV 60K CP-P and describe their response to CPMV infection.
Methods
Virus purification. The SB strain of CPMV (obtained from O. W. Barnett, Clemson University, Clemson, S.C., U.S.A.) was increased in Vigna unguiculata Walp. cv. Early Ramshorn. Virus purification was by the method of Ghabrial & Schultz (1983) previously reported for the purification of bean pod mottle virus. Purified virus was quantified by its absorbance at 260 nm assuming 8-1 A26 o = 1 mg nucleoprotein/ml (van Kammen & de Jager, 1978) .
Plasmids. pSPBa1709 was derived from clone M 13-3'M4 (Holness et al., 1989) which contained the CPMV 60K CP-P coding region and flanking sequences [M-RNA sequences starting from the BamHI site at position 1504 and continuing through the entire 3' end of the molecule including 17 A residues of the poly(A)tail]. The insert in M 13-3'M4 was cloned into BamHl/Hincll-cut M13mpl9. To remove most of the sequence upstream of the Met codon which marks the start of the coat protein sequence, M13-3'M4 was cut with BamHI and a 761 bp Sau3AT fragment, derived from bases 2067 to 2828 of the CPMV B-RNA sequence, was inserted at the BamHI site. This fragment was used as a 'filler' to allow effective unidirectional deletions to be made by Bal 31 exonuclease. It was selected because it restored the BamHI site at one side of the insertion but not the other. The restored BamHI site was the one near the beginning of the CPMV coat protein sequence. The resulting construct was cut with BamHI and digested for various lengths of time with Bal 31. After termination of the digestion, the DNA was restricted with XmaI, the protruding 5" termini were filled in with Klenow enzyme and dNTPs, and the vector was religated and used to transform Escherichia coli strain JM 101. A number of plaques were isolated and the extent of the deletion was determined by sequence analysis. One clone, MI3Bal-7, had the sequence between nucleotides 1504 and 1524 deleted, thereby removing the two upstream AUG codons which had interfered in previous translation experiments. The replicative form of clone M13Bal-7 was digested with EcoRI and PstI, and the DNA fragment was isolated and inserted into the transcription vector pSPTI9 (Pharmacia) which had been previously digested with EcoRI and PstI. The resulting construct, pSPBal7, in which the coat protein sequence was downstream of an SP6 promoter, was found to have a single base deletion at position 2419 of the M-RNA. This was corrected by replacing the 784 bp EcoRV fragment from pSPBaI7 with that from a clone which did not have the deletion, thus giving rise to pSPBaI709.
pMON-CCP60. An expression vector containing the CPMV 60K CP-P coding region was constructed for tobacco transformation as follows: the CPMV 60K coding sequence, derived from pSPBal709 as a KpnI/PstI fragment, was inserted into the Smal site of the binary Ti vector pMON530 (Rogers et al., 1987) by dG :dC homopolymeric tailing (Eschenfeldt et al., 1987) . The resultant positive-sense construct, as determined by HindlII restriction analysis, was designated pMON-CCP60.
Tobacco transformation. A freezing and thawing method was employed to transform disarmed Agrobacterium tumefaciens Z707 directly with pMON-CCP60 (Holsters et al., 1978) . A. tumefaciens was also transformed with pMON530 for the purpose of producing vectortransformed control plants. Sterile leaf discs of Nicotiana tabacum cv. Burley 21 were transformed by co-cultivation with A. tumefaciens (Horsch et al., 1985) . The discs were immersed in the bacterial suspension in Lnria broth, blotted on filter paper, and placed on modified Linsmaier and Skoog medium (Kasperbauer & Collins, 1972) for 48 h. Discs were transferred to, and regenerated on, selective modified Linsmaier and Skoog medium containing 500 ~tg/ml mefoxin and 100 ~tg/ml kanamycin. Shoots were rooted on R1/2N medium (Nitsch, 1969) containing 500 ~tg/ml mefoxin and 100 ~tg/ml kanamycin. Plantlets were potted into sterile Promix B (Premier Brands), and established in a growth chamber at 25 + 5 °C with a 14 h photoperiod. Once the regenerated plants were established, leaf discs were removed, their surfaces were sterilized, and the discs were placed on selective modified Linsmaier and Skoog medium. Plants capable of forming callus in the presence of kanamycin were further analysed for gene integration and expression. Plants transformed with the CP-P coding sequence were designated KM-1, KM-2, etc. The vector-transformed plants were denoted MON-1, MON-2, etc.
Southern blots. Total nucleic acid preparations from regenerated tobacco plants were made by the CTAB procedure as described by Rogers & Bendich (1988) . The DNA was doubly digested with EcoRI/Stul and subjected to electrophoresis in 0.8~ agarose gel. The DNA was transferred onto GeneScreen (New England Nuclear) according to the manufacturer's instructions and hybridized to a 32p_ labelled cDNA oligonucleotide probe of the CPMV 60K coding region (Feinberg & Vogelstein, 1985) . The blot was washed, dried and autoradiographed.
RNA dot blot. RNA samples (50 ~tg) extracted from transgenic plants were denatured in 50~ formamide and 6~ formaldehyde at 60 °C for 10 rain. The RNA samples were diluted with an equal volume of distilled water, applied to GeneScreen Plus by use of a dot blot manifold (Schleicher & Schuell) and hybridized with a 32P-labelled cDNA oligonucleotide probe representing the 60K coding region.
Serology. The CPMV 60K CP-P was detected in transgenic plants and progeny by either the standard direct double antibody sandwich ELISA as described by Ghabrial & Schultz (1983) or, in some experiments, the indirect ELISA procedure described by Anderson et al. (1991) was followed, except that the plant samples were homogenized (1:5 w/v) in PBS pH 7.4, instead of the sodium carbonate buffer pH 9.6.
Western blots. Leaf samples from transgenic plants were chopped in 0.75 mM-Tris HC1 pH 6.8 sample buffer (1 : 1 w/v) containing 10 mM-2-mercaptoethanol and 9 M-urea. The mixture was filtered through 10 Ixm nylon mesh and the filtrate was designated filtrate 1. The residue was then soaked in 0.5 volume of sample buffer for 15 min, boiled for 15 min and subsequently filtered through 10 ~tm nylon mesh to give filtrate 2. Concentrated Laemmli loading buffer (Laemmli, 1970) was added to each of filtrates 1 and 2 to a final concentration of 1 x, boiled for 5 min, and samples were subjected to electrophoresis in 10~ polyacrylamide gel. Proteins were electrophoretically transferred onto ImmobiIon potyvinylidene difluoride membrane (Millipore) with 25 mM-Tris-HCI pH 7-5 containing 190 mM-glycine and 15 ~ methanol (Towbin et al., 1979) . The membrane was blocked with BLOTTO, 5~ (w/v) Carnation non-fat dry milk and 0.1 ~ sodium azide in TBS (20 mMTris-HC1 buffer pH 7.5, containing 0.5 M-sodium chloride), washed with TBS~-05 ~ Tween 20, and incubated with 2 ~g/ml CPMV IgG in BLOTTO containing 0.05~ Tween 20. The blot was washed, reacted with 125I-labelled protein A (Burnette, 1981) , dried and autoradiographed.
lmmunosorbent electron microscopy (IEM). In order to determine whether CPMV 60K CP-P produced in transgenic plants may assemble into capsids, clarified leaf extracts from the transgenic plants expressing CPMV 60K CP-P and the vector-transformed control plants were examined by IEM using an antiserum to CPMV. Purified CPMV and extracts from non-transformed mock-and CPMVinoculated tobacco plants served as controls.
Infectivity assays. In order to assess the susceptibility of transgenic tobacco plants to infection with CPMV, the following experiments were carried out. Transgenic plants grown from seeds of primary transformants shown to express CPMV 60K polyprotein, as determined by ELISA, were used. The upper right-hand quadrant of the Carborundum-dusted youngest nearly fully expanded leaf (leaf three) of transgenic plants in the five-leaf stage was inoculated with 100 p~l of purified CPMV at a concentration of 1 to 10 ~g/ml. The virus titres in the inoculated and non-inoculated quadrants of leaves from CPMV 60K expressers and vector control plants were determined by direct ELISA and/or RNA dot blot hybridization using a 32p-labelled oligonucleotide probe derived from cloned cDNA to CPMV B-RNA.
Results

Construction and properties of pSPBal 709
Nucleic acid and protein sequencing data have shown that the CPMV 60K CP-P is encoded by residues 1538 to 3298 of the M -R N A sequence (van Wezenbeek et al., 1983) . To express the authentic protein, we made use of the fact that it is released from the M-RNA-encoded polyproteins by cleavage at a glutamine-methionine dipeptide (van Wezenbeek et al., 1983) . Thus the M-R N A sequence which encodes the 60K protein starts with an A U G codon. Inspection of the sequence around this A U G codon revealed that it appears, fortuitously, to be in a relatively good context (Lutcke et al., 1987) to serve as an initiator for protein synthesis. We therefore produced a clone, pSPBaI709, which contains the sequence of CPMV M -R N A between nucleotides 1525 and the 3' terminus of the R N A [including part of the poly(A) tail] downstream of an SP6 promoter. The clone was designed so that in vitro transcription would result in the synthesis of R N A encoding the whole of the 60K sequence and in which the A U G at position 1538 is the 5' proximal A U G .
In vitro transcription of PstI-linearized pSPBal709 with SP6 polymerase resulted in the synthesis of R N A with the expected size of 2-0 kb. Translation of the transcripts in a rabbit reticulocyte lysate system resulted in the synthesis of large amounts of a 60K protein, the mobility of which was identical to that of the 60K CP-P produced by processing the M-RNA-encoded polyproteins (data not shown). This demonstrates that the A U G at position 1538 can act as an initiator of protein synthesis when it is 5' proximal on an RNA. The insert from pSPBaI709 was therefore considered suitable for obtaining 60K expression in transgenic tobacco plants. 
Integration and expression of the chimeric C P M V 60K gene
Of a total of seven kanamycin-resistant tobacco plants, four (KM-6, KM-7, KM-8 and KM-9) were selected for further analysis based on accumulated levels of CP-P, as determined by ELISA. The presence of integrated CPMV 60K CP-P coding region in these transgenic plants was confirmed by Southern blot analysis. The CP-P coding region probe hybridized to a 4 kbp D N A fragment, the expected size for StuI-EcoRI digests of D N A from plants transformed with CP-P coding sequence (Fig. 1) . No hybridization was detected with D N A from the vector-transformed control plant, MON-3. Expression of the integrated chimeric genes was analysed by R N A dot blot hybridization. R N A samples from transgenic plants were spotted in duplicate dots and hybridized to the CPMV 60K CP-P probe. Hybridization was evident with plant samples KM-6, KM-7, KM-8 and KM-9 as well as with dilutions of purified C P M V M- RNA from KM-9 (dots 1 and 2), KM-8 (dots 3 and 4) and KM-7 (dots 5 and 6). Row C: RNA from KM-6 (dots 1 and 2) and MON-4 (dots 3 and 4).
RNA (Fig. 2). Variable levels of transcription were detected as indicated by the variation in dot intensity.
Approximately 20 ng RNA can be estimated for each of KM-6, KM-8 and KM-9, but only about 5 ng RNA was estimated for KM-7. No hybridization signals were observed with RNA samples from the vector-transformed plant MON-4.
Protein expression in transgenic plants
A protein with an estimated Mr of 60K was detected in Western blots of filtrate 2 samples (see Methods) prepared from the transgenic plant KM-9 using an antiserum to CPMV virions and lZSI-Protein A (Fig. 3 , lane 1). No protein bands were observed in such blots with filtrate l samples from CP-P-transformed plants or with any of the samples from vector-transformed control 1" Samples collected from inoculated regions 24 h post-inoculation gave ELISA absorbance values similar to those obtained with mockinoculated plants.
The non-inoculated quadrants were on the same half of the leaf as the inoculated quadrants.
§ Values are means of three replicates _+ standard deviation. Samples of purified CPMV at concentrations of 1.0, 0.1 and 0.01 gg/ml, which were included in the same ELISA plate, gave readings of >2.0, 0.240 +_ 0-068, and 0.044 _+ 0.014, respectively. t r a n s f o r m e d tobacco and in purified C P M V p r e p a r ations (data not shown).
The resident C P M V antigen in transgenic tobacco plants was readily detected using a variation of an indirect E L I S A m e t h o d and an antiserum to C P M V virions. The use of PBS in place of carbonate buffer, in the p r e p a r a t i o n of leaf extracts and the coating of polystyrene plates, significantly e n h a n c e d the sensitivity of indirect E L I S A in detecting C P M V C P -P (Table 1) . The E L I S A d a t a indicated that higher levels of C P -P accumulation were detected in the transgenic plants K M -8 and K M -9 than were detected in K M -6 (Table 1) . E L I S A testing of seedling progeny from four selffertilized p r i m a r y t r a n s f o r m a n t s indicated that the progeny segregated at a M e n d e l i a n ratio of 3 : 1 (express e r s : n o n -e x p r e s s e r s of C P M V CP-P). The level of C P M V C P -P accumulated in the transgenic plants was estimated, using direct E L I S A , to be equivalent to 0.5 to 2.0 gg/g wet weight of tissue. A s s u m i n g that soluble proteins constitute 10~ of the leaf dry weight and that dry weight is 1 0~ of the wet weight, then C P M V 60K C P -P in transgenic plants represents 0.005 to 0 -0 2~ of total soluble proteins.
The 60K principal translation product of in vitro transcription of linearized pSPBal709, as described before, was specifically i m m u n o p r e c i p i t a t e d with the same antiserum to C P M V virions used in E L I S A (data not shown). Thus, the resident C P M V 60K protein detected in the transgenic plants by W e s t e r n blots and E L I S A is the product of the C P -P coding region. Twofold dilutions of total nucleic acids extracted from 8 mg tissue were made from inoculated and non-inoculated quadrants of the individual leaves, spotted onto GeneScreen Plus membranes and probed with 32p. labelled cloned B-RNA cDNA probe. Unless otherwise specified, samples in columns 1 to 3 and 7 to 9 were from inoculated quadrants; samples in columns 4 to 6 and 10 to 12 were from non-inoculated quadrants. In all cases, the lowest dilution was spotted in the first dot and the highest in the third dot. The samples used were as follows. Row A: 1 to 6, KM-9 (2); 7 to 12, MON-3 (2); row B: 1 to 6, KM-6 (4); 7 to 12, KM-9 (6); row C: 1 to 6, MON-3 (1); 7 to 12, KM-6 (6); row D: 1 to 6, KM-9 (5); 7 to 12, MON-3 (4); row E: 1, mock-inoculated control; 2 to 6, purified B-RNA in amounts of 100, 50, 25, 10 and 1 ng/dot, respectively; 7 to 12, KM-6 (5); row F: 1, 2, 3, 5 and 6, twofold dilutions of total nucleic acids extracted from 4 mg tissue of CPMV-inoculated cowpea.
Reaction of transgenic plants to virus infection
A l t h o u g h C P M V neither induces visible s y m p t o m s in inoculated tobacco plants nor moves systemically in infected plants, it replicates to a relatively high concentration in the inoculated leaf. One week post-inoculation, C P M V accumulated to a p p r o x i m a t e l y 50 and 5 gg/g wet weight tissue in the inoculated and non-inoculated quadrants, respectively, of the i n d i v i d u a l treated leaves of n o n -t r a n s f o r m e d tobacco (Table 2) . A n inoculum concentration of 10 gg/ml was used in all infectivity assays because p r e l i m i n a r y experiments with virus inoculum at 1 and 5 gg/ml did not consistently produce detectable virus levels, within 2 weeks after inoculation, in n o n -t r a n s f o r m e d or vector-transformed plants. To evaluate the reactions of the transgenic plants to C P M V inoculation, we relied on dot blot h y b r i d i z a t i o n assays of total nucleic acid p r e p a r a t i o n s from inoculated and noninoculated q u a d r a n t s of individual leaves using a 3zp. labelled oligonucleotide probe generated from cloned c D N A to C P M V B -R N A . Results from a representative dot blot analysis are shown in Fig. 4 . Because of the variability in the virus level in inoculated leaves of
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vector-transformed plants as well as among those transformed with the CPMV 60K CP-P sequence, it was not possible to correlate the expression of CP-P with the level of challenge virus replication and movement. Higher virus levels were detected in the non-inoculated quadrants of KM-6(6) and KM-9(5), transgenic progeny considered to be low expressers of CP-P as determined by ELISA prior to inoculation (Fig. 4 , row C, dots 10 to 12, and row D, dots 4 to 6, respectively). The ELISA values for extracts from these two plants were less than half those obtained for extracts from the other CP-P expressers (data not shown). The dot blot experiments were repeated 4 times with similar results. An ELISA was also used to evaluate the response of transgenic plants to CPMV infection. Like those of the dot blot assays, results of ELISA testing of inoculated leaves could not differentiate among CP-P expressers, non-expressers, and vector-transformed controls (data not shown).
Discussion
The results of Southern blot analysis confirmed the integration of the CPMV 60K CP-P coding region in the genome of transgenic tobacco plants. Data from RNA dot blots, ELISA and Western blotting experiments demonstrated expression of the integrated CP-P gene. The level of CPMV CP-P production is within the range (0.002~ to 0-2~ of total soluble proteins) reported in transgenic plants transformed with the coat protein genes of viruses whose capsids are composed of a single type of coat protein (Cuozzo et al., 1988; Hemenway et al., 1988; Lawson et al., 1990; Loesch-Fries et al., 1987; van Dun et al., 1987) . The results of Western blots and IEM also indicated that CPMV CP-P neither undergoes autoproteolysis to generate the mature viral coat proteins, nor assembles into virus-like capsids. Because purified preparations of CPMV, isolated from cowpea plants, are known to contain empty protein capsids (top component), in addition to the nucleoprotein middle and bottom components, these data suggest that processing of CPMV CP-P may be required for capsid assembly. There could, however, be other explanations. For example, tobacco is not a natural host of CPMV, and consequently the concentration and cellular distribution of CP-P may be different from that in cowpea and unsuitable for empty capsid assembly. Furthermore, it is not known whether encapsidation of viral RNA follows, occurs concomitantly with, or is independent of CP-P processing. A recent report on the detection of empty virus-like particles in transgenic plants expressing the coat protein of arabis mosaic virus, a nepovirus containing a single type of coat protein (Bertioli et al., 1991) , is of interest in this regard.
A modification of an indirect ELISA procedure that involves substituting PBS pH 7.4 for carbonate buffer pH 9.6 [a commonly used buffer for coating the ELISA plates with the initial reactant (Clark et al., 1986) ] significantly enhanced the sensitivity of indirect ELISA in detecting CPMV CP-P in transgenic plants. Some viruses dissociate in a high pH buffer such as the carbonate buffer whereas incubation in a neutral pH buffer, i.e. PBS, does not affect particle integrity (Murphy & D'Arcy, 1991) . Although we do not know the effect of carbonate buffer on the state of aggregation of CP-P in leaf extracts, the antiserum used in ELISA was raised against CPMV virions and may thus have higher affinity to CP-P in a more aggregated form.
Results of infectivity assays, designed to compare the virus titre in leaves of transgenic tobacco plants inoculated with purified CPMV at a concentration of 10 ~tg/ml, showed little or no differences between CP-P expressers and vector-transformed plants. Huber et al. (1977) reported a longer lag period prior to detectable virus multiplication in tobacco protoplasts inoculated with CPMV compared to cowpea protoplasts. Such a lag period might mask a delay in virus replication resulting from the presence of the endogenous 60K CP-P.
As it is not known how constitutive expression of the coat protein gene confers resistance to viruses whose capsids contain single coat proteins, one cannot predict how efficient the precursor strategy would be. In a recent review (Beachy et al., 1990) , the authors advanced the following hypotheses to explain how the resident CP may interfere with some early events in virus infection: (i) the resident CP may inhibit uncoating of incoming virus particles and/or (ii) the CP may bind to the viral RNA thus interfering with gene expression. These hypotheses have been based on several types of experiments involving different RNA viruses with capsids made up of single coat proteins. This raises the interesting question of whether a precursor molecule is capable of performing the same protection-mediated functions as do the mature viral proteins. The conformation of the precursor molecule is expected to be quite distinct from that of the individual mature proteins. Recent X-ray crystallographic studies by Chen et al. (1989) have suggested that substantial rearrangements occur in portions of the two capsid proteins of the comovirus BPMV after post-translational cleavage of the precursor. It will be of considerable interest to determine whether differences in conformation between the precursor to the coat proteins and the individual mature viral proteins have a bearing on their distribution in the cell and, in turn, on their abilities to bind to viral RNA and/or to inhibit uncoating of challenge virus particles.
The transgenic tobacco plants expressing CPMV 60K CP-P have provided us with excellent experimental material to investigate various aspects of the molecular biology of comoviruses. Studies involving electroporation of protoplasts, generated from CP-P expressers, with infectious full-length transcripts from cloned B-RNA cDNA are under way in our laboratory to examine CP-P processing and capsid assembly in vivo.
